TICKERNOMICS Sign up
Last Update: 2024-12-27 15:27:02
Brainsway Ltd. ( BWAY ) https://www.brainsway.com
9.37USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
Israel
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
BWAY
47.56%
SPY
32.66%
BWAY
20.44%
SPY
108.59%
-3.30%
BWAY
SPY
302.52%
BWAY
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
152.92
104.79
0.03
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
101.95
3.96
3.47
4.91
0.00
38.08
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
2.68
73.52
6.86
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
8.6256
2.93
2.27
1.17
Other Earnings and Cash Flow Stats:
Brainsway Ltd. ( BWAY ) Net Income TTM ($MM) is 1.50
Brainsway Ltd. ( BWAY ) Operating Income TTM ($MM) is 1.14
Brainsway Ltd. ( BWAY ) Owners' Earnings Annual ($MM) is 0.74
Brainsway Ltd. ( BWAY ) Current Price to Owners' Earnings ratio is 145.65
Brainsway Ltd. ( BWAY ) EBITDA TTM ($MM) is 2.55
Brainsway Ltd. ( BWAY ) EBITDA Margin is 6.86%
Capital Allocation:
Brainsway Ltd. ( BWAY ) has paid 0.00 dividends per share and bought back -0.407692 million shares in the past 12 months
Brainsway Ltd. ( BWAY ) has increased its debt by 0.0 million USD in the last 12 months
Capital Structure:
Brainsway Ltd. ( BWAY ) Interest-bearing Debt ($MM) as of last quarter is 0
Brainsway Ltd. ( BWAY ) Annual Working Capital Investments ($MM) are -1
Brainsway Ltd. ( BWAY ) Book Value ($MM) as of last quarter is 44
Brainsway Ltd. ( BWAY ) Debt/Capital as of last quarter is 0%
Other Balance Sheet Stats:
Brainsway Ltd. ( BWAY ) has 48 million in cash on hand as of last quarter
Brainsway Ltd. ( BWAY ) has 12 million of liabilities due within 12 months, and long term debt 0 as of last quarter
Brainsway Ltd. ( BWAY ) has 16 common shares outstanding as of last quarter
Brainsway Ltd. ( BWAY ) has 0 million USD of preferred stock value
Academic Scores:
Brainsway Ltd. ( BWAY ) Altman Z-Score is 2.68 as of last quarter
Brainsway Ltd. ( BWAY ) Piotroski Score is 5.00 as of last quarter
Corporate Governance:
Brainsway Ltd. ( BWAY ) largest shareholder is Cubist Systematic Strategies, LLC owning 16782 shares at 0.16 ($MM) value
(an insider) shares of Brainsway Ltd. ( BWAY ) for the amount of $ on
5.00% of Brainsway Ltd. ( BWAY ) is held by insiders, and 19.22% is held by institutions
Brainsway Ltd. ( BWAY ) went public on 1999-10-06
Other Brainsway Ltd. ( BWAY ) financial metrics:
FCF:5.94
Unlevered Free Cash Flow:-3.83
EPS:0.16
Operating Margin:2.68
Gross Profit Margin:73.52
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:6.01
Beta:1.17
Buffet's Owners Earnings:0.74
Price to Owner's Earnings:145.65
About Brainsway Ltd. ( BWAY ) :
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, the Asia Pacific, Europe, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.